Abhay Joshi - 15 Feb 2022 Form 4 Insider Report for Revance Therapeutics, Inc.

Role: COO, President, R&D
Signature: /s/ Terri McDowell, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 15 Feb 2022
Net transactions value: -$67,458
Form type: 4
Filing time: 17 Feb 2022, 19:51:57 UTC
Next filing: 17 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RVNC	Common Stock	Tax liability	$28,716	-2,151	-1.7%	$13.35	126,217	15 Feb 2022	Direct	F1
transaction	RVNC	Common Stock	Tax liability	$38,742	-2,902	-2.3%	$13.35	123,315	15 Feb 2022	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares withheld by and surrendered to the Issuer on February 15, 2022, to satisfy tax withholding obligations that arose in connection with the vesting of Restricted Stock award ("RSA") for 15,750 shares. The RSA vests in three equal annual installments from February 15, 2019, subject to Dr. Joshi's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan (the "Plan.")) on each vesting date.
F2	Represents the number of shares withheld by and surrendered to the Issuer on February 15, 2022, to satisfy tax withholding obligations that arose in connection with the vesting of an RSA for 25,000 shares. The RSA vests in three equal annual installments from February 15, 2020, subject to Dr. Joshi's Continuous Service (as defined in the Plan) on each vesting date.

Content

Represents the number of shares withheld by and surrendered to the Issuer on February 15, 2022, to satisfy tax withholding obligations that arose in connection with the vesting of Restricted Stock award ("RSA") for 15,750 shares. The RSA vests in three equal annual installments from February 15, 2019, subject to Dr. Joshi's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan (the "Plan.")) on each vesting date.

Represents the number of shares withheld by and surrendered to the Issuer on February 15, 2022, to satisfy tax withholding obligations that arose in connection with the vesting of an RSA for 25,000 shares. The RSA vests in three equal annual installments from February 15, 2020, subject to Dr. Joshi's Continuous Service (as defined in the Plan) on each vesting date.